This free sheet contains 100 accelerators and incubators you can apply to today, along with information about the industries they generally invest in.
This free sheet contains all the information about the top 100 unicorns, including their valuation, HQ's location, founded year, name of founders, funding amount and number of employees.
This free Notion document contains the best 100+ resources you need for building a successful startup, divided in 4 categories: Fundraising, People, Product, and Growth.
The medical startup scene is seeing major investment across various specializations. Companies are tackling everything from elder care to neurotechnology.
For example, Neuralink has raised $1.3 billion to develop brain-computer interfaces. Meanwhile, newer companies like Aster are addressing specific needs like OB/GYN clinic management.
Below is our list of 100 Medical startups worth keeping an eye on.
Everything you need to raise funding for your startup, including 3,500+ investors, 7 tools, 18 templates and 3 learning resources.
Buy It For $97 $297 →Information about the industries, countries, and cities they generally invest in.
Get the Sheet for $50Information about their valuation, HQ's location, founded year, name of founders, funding amount and number of employees.
Get the Sheet for $50List of startup investors in the BioTech, Health, and Medicine industries, along with their Twitter, LinkedIn, and email addresses.
Get the Sheet for $50List of 250 startup investors in the AI and Machine Learning industries, along with their Twitter, LinkedIn, and email addresses.
Get the Sheet for $50List of 250 startup investors in the FinTech and Finance industries, along with their Twitter, LinkedIn, and email addresses.
Get the Sheet for $50Honor has built the world's largest home care network, connecting local agencies and care professionals with families seeking support for aging loved ones. Their technology platform helps modernize agency operations and provides caregivers with tools to deliver high quality in-home care.
OpenEvidence builds an AI-powered search engine designed for medical professionals to find clinical answers. The platform provides evidence-based support for treatment decisions by rapidly analyzing medical literature.
Neuralink develops brain-computer interfaces designed to treat neurological disorders. Their technology aims to restore autonomy for people with paralysis by enabling them to control computers and mobile devices directly with their thoughts.
Midi Health runs a virtual clinic delivering expert care for women navigating perimenopause, menopause, and other midlife hormonal changes. Their service connects patients with trained specialists who develop personalized treatment plans to address a wide range of symptoms.
Ambience Healthcare has built an AI operating system that automates critical workflows for healthcare organizations, from clinical documentation to coding. Their suite of tools helps reduce the administrative burden on clinicians, allowing them to focus more on patient care.
Aster builds an AI-powered operating system specifically for OB/GYN and women’s health practices. The platform is designed to streamline clinic operations, automate clinical documentation, and improve the patient experience.
OrganOx builds a transportable medical device that keeps donor organs warm and functional outside the body. Their technology is designed to extend the time an organ is viable for transplant, improving the quality of the organ and increasing the chances of a successful surgery.
MoldCo has built a digital health platform for mold exposure care. Their service connects patients with specialized consultations, at-home testing, and personalized treatment plans.
Thyme Care created a value-based care model that provides comprehensive navigation and support for cancer patients. They partner with health plans and oncologists to guide individuals through their treatment journey, aiming to improve both the experience and outcomes.
Avenzo Therapeutics develops next-generation oncology therapies for patients with cancer. Their team advances a portfolio of promising clinical-stage treatments designed to address significant unmet needs in cancer care.
Our top 10 picks offer a glimpse into a much larger movement. Combined, the companies on our full list have raised over $20 billion, tackling big problems in areas like biotech and AI.
You'll find a mix of newcomers and more established names. Here are the other companies making a mark on the medical industry.
| Startup | Main Industry | Year Founded | Amount Raised | Last Funding Round |
|---|---|---|---|---|
| Education | 2021 | $31.5M | Series A | |
| Healthcare | 2015 | $506.6M | Series D | |
| Healthcare | 2022 | $57.5M | Series A | |
| AgTech | 2019 | $210M | Series D | |
| AI | 2021 | $601.7M | Venture Round | |
| Biotech | 2012 | $3.5B | Corporate Round | |
| Healthcare | 2014 | $250.9M | Venture Round | |
| Biotech | 2007 | $496.4M | Series D | |
| Analytics | 2022 | $36.4M | Series A | |
| AI | 2023 | $38M | Series A | |
| Healthcare | 2021 | $17.5M | Series A | |
| AI | 2016 | $414M | Venture Round | |
| Healthcare | 2019 | $242M | Series C | |
| Biotech | 2021 | $1.1B | Series A | |
| Enterprise | 2014 | $271.1M | Venture Round | |
| Healthcare | 2020 | $178M | Series C | |
| AI | 2024 | $25M | Series A | |
| Healthcare | 2022 | $56M | Series B | |
| Biotech | 2023 | $19.5M | Seed | |
| Healthcare | 2013 | $184M | Series D | |
| AI | 2015 | $23.8M | Series B | |
| Healthcare | 2022 | $255.5M | Series B | |
| Healthcare | 2015 | $248.5M | Series C | |
| AI | 2019 | $69M | Series B | |
| Biotech | 2016 | $600M | Venture Round | |
| Biotech | 2021 | $65M | Series A | |
| Fintech | 2016 | $419.4M | Series D | |
| AI | 2020 | $115.1M | Series B | |
| Healthcare | 2019 | $30.5M | Series A | |
| Biotech | 2019 | $6.2M | Series A | |
| AI | 2022 | $103.1M | Series A | |
| Healthcare | 2020 | $3.8M | Seed | |
| Education | 2022 | $104.6M | Series B | |
| Healthcare | 2013 | $180.9M | Series D | |
| Biotech | 2009 | $472.6M | Series H | |
| Healthcare | 2020 | $8.9M | Seed | |
| Healthcare | 2014 | $144.3M | Series D | |
| AI | 2021 | $161M | Series C | |
| Healthcare | 2018 | $315M | Series D | |
| Biotech | 2019 | $332M | Venture Round | |
| Biotech | 2015 | $30.2M | Series A | |
| AI | 2015 | $493.5M | Venture Round | |
| Biotech | 2010 | $78.5M | Venture Round | |
| Biotech | 2019 | $355M | Series C | |
| AI | 2014 | $129.8M | Series D | |
| Biotech | 2016 | $425.9M | Series D | |
| Healthcare | 2017 | $588M | Series F | |
| AI | 2017 | $59.2M | Venture Round | |
| Biotech | 2014 | $456M | Series D | |
| Retail | 2015 | $40.5M | Series B | |
| Healthcare | 2015 | $49.5M | Venture Round | |
| Biotech | 2019 | $258M | Venture Round | |
| AI | 2018 | $757.5M | Series E | |
| Enterprise | 2018 | $306.3M | Venture Round | |
| Healthcare | 2010 | $108.5M | Series D | |
| Healthcare | 2015 | $91M | Series C | |
| Healthcare | 2022 | $14.3M | Seed | |
| Biotech | 2019 | $237M | Series B | |
| Healthcare | 2019 | $176.8M | Series C | |
| Biotech | 2021 | $79.5M | Grant | |
| Biotech | 2021 | $38M | Series B | |
| Biotech | 2017 | $1.1B | Grant | |
| Biotech | 2012 | $1B | Series C | |
| Sports | 1995 | $52.6M | Series C | |
| Sports | 2012 | $12.2M | Venture Round | |
| Healthcare | 2020 | $22M | Series A | |
| AI | 2022 | $32M | Series A | |
| Healthcare | 2022 | $2.4M | Seed | |
| Healthcare | 2009 | $769M | Debt Financing | |
| Biotech | 2018 | $640.6M | Series D | |
| Healthcare | 2014 | $150M | Series B | |
| Healthcare | 2020 | $5M | Seed | |
| Healthcare | 2021 | $75M | Series A | |
| Biotech | 2013 | $271.3M | Series F | |
| Biotech | 2007 | $28.1M | Series C | |
| Biotech | 2009 | $51.9M | Series B | |
| Biotech | 2021 | $187.3M | Series C | |
| Healthcare | 2022 | $200M | Private Equity | |
| Biotech | 2022 | £8.8M | Seed | |
| Biotech | 2019 | $117.6M | Series A | |
| Healthcare | 2008 | $36.4M | Grant | |
| Biotech | 2018 | $346.1M | Series D | |
| AI | 2016 | $76M | Venture Round | |
| Manufacturing | 2017 | $291.7M | Series B | |
| Biotech | 2021 | $3B | Series A | |
| AI | 2016 | $125.3M | Series D | |
| Healthcare | 2016 | $122.2M | Series B | |
| Healthcare | 2019 | $135.8M | Series D | |
| Healthcare | 2009 | $74M | Venture Round | |
| Healthcare | 2016 | $29.2M | Convertible Note |
